Regulatory Factors Influencing Usage of Retinal Pharmaceuticals: A Look Both Home and Abroad. [electronic resource]
- American journal of ophthalmology 09 2016
- xiv-xvi p. digital
Publication Type: Editorial
1879-1891
10.1016/j.ajo.2016.06.040 doi
Angiogenesis Inhibitors--administration & dosage Clinical Trials, Phase III as Topic Diabetic Retinopathy--drug therapy Drug and Narcotic Control--legislation & jurisprudence Drug-Related Side Effects and Adverse Reactions--prevention & control European Union Humans Legislation, Drug--organization & administration Macular Degeneration--drug therapy Pharmaceutical Preparations--administration & dosage Retinal Vein Occlusion--drug therapy United States Vascular Endothelial Growth Factor A--antagonists & inhibitors